MassDevice: Not A Lot Of Bargains Among Med-Tech Stocks

Medical technology stocks of all stripes have been enjoying a pretty exceptional run in the market, as healthcare has actually been 1 of the leading sectors in the recent rally. Unfortunately for investors, however, revenue, profits, and free cash flow have not been improving at the same rate, and the number of real bargains in the market has shrunk noticeably. While there are still a few opportunities that look undervalued, investors are increasingly finding themselves faced with a limited menu of attractive options.

Please read more here:
http://www.massdevice.com/blogs/massdevice/not-lot-bargains-among-medtech-stocks

Seeking Alpha: Endologix Shows How Growth-Hungry Med-Tech Investors Are

Since it seems to be accepted practice now to accuse anyone who doesn't think your stock is a screaming buy today with being "secretly short", let me be very clear from the get-go - I like Endologix (ELGX) quite a lot as a company, I think the company's technology is innovative, and I see the company as both a share-gainer in endovascular AAA treatment and one of the best growth stories today in med-tech. All of that said, I don't see it as a bargain unless/until a larger med-tech company decides that it must have it as its own.

Please continue here:
Endologix Shows How Growth-Hungry Med-Tech Investors Are